Topical Itraconazole for the Treatment of Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome or High-Frequency Basal Cell Carcinomas: A Phase 2, Open-Label, Placebo-Controlled Trial

JAMA Dermatol. 2019 Sep 1;155(9):1078-1080. doi: 10.1001/jamadermatol.2019.1541.

Authors

Grace K Sohn¹, Gina P Kwon¹, Irene Bailey-Healy¹, Amar Mirza^{1

2}, Kavita Sarin¹, Anthony Oro^{1

2}, Jean Y Tang¹

Affiliations

¹ Department of Dermatology, Stanford University, Stanford, California.
² Program in Epithelial Biology, Stanford University School of Medicine, Stanford, California.

Abstract

This phase 2, open-label, placebo-controlled examines topical itraconazole as a treatment for basal cell carcinoma.

Grants and funding